The next round of meeting with pharma lobby groups such as Indian Pharmaceutical Alliance (IPA), Indian Drugs Manufacturers' Association (IDMA), and officials from pharma companies is slated scheduled for 9 January. NITI Aayog had earlier sent a three-page questionnaire to the lobby groups, which ...
Read more: NITI Aayog may revamp process of drug selection for price control